Your browser doesn't support javascript.
loading
Development and pilot validation of a novel disfigurement severity scale for plexiform neurofibromas in children with neurofibromatosis type 1.
John, Liny; Singh, Gurbani; Dombi, Eva; Wolters, Pamela L; Martin, Staci; Baldwin, Andrea; Steinberg, Seth M; Bernstein, Jessica; Whitcomb, Patricia; Pichard, Dominique C; Dufek, Anne; Gillespie, Andy; Heisey, Kara; Bornhorst, Miriam; Fisher, Michael J; Weiss, Brian D; Kim, AeRang; Widemann, Brigitte C; Gross, Andrea M.
Afiliação
  • John L; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Singh G; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Dombi E; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Wolters PL; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Martin S; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Baldwin A; Clinical Research Directorate (CRD), Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Steinberg SM; Biostatistics and Data Management Section, Office of the Clinical Director, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Bernstein J; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Whitcomb P; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Pichard DC; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Dufek A; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Gillespie A; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Heisey K; Clinical Research Directorate (CRD), Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
  • Bornhorst M; Center for Cancer and Blood Disorders, Children's National Hospital, Washington, DC, USA.
  • Fisher MJ; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  • Weiss BD; Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
  • Kim A; Center for Cancer and Blood Disorders, Children's National Hospital, Washington, DC, USA.
  • Widemann BC; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Gross AM; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Clin Trials ; 21(2): 189-198, 2024 04.
Article em En | MEDLINE | ID: mdl-37877369

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neurofibromatose 1 / Neurofibroma Plexiforme Limite: Child / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neurofibromatose 1 / Neurofibroma Plexiforme Limite: Child / Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article